Zynex, Inc. - Common Stock (ZYXI)
Frequently Asked Questions About Zynex, Inc. - Common Stock (ZYXI)
Are there any partnerships associated with Zynex, Inc.?
Zynex, Inc. engages in partnerships with healthcare providers, distributors, and research institutions to enhance its service offerings and expand its market presence. These collaborations enable the company to leverage expertise and resources, allowing for the development of innovative products that meet the needs of both providers and patients.
How does Zynex, Inc. address regulatory changes in healthcare?
Zynex, Inc. actively monitors regulatory changes in the healthcare landscape to ensure compliance with evolving standards and guidelines. The company's regulatory and compliance teams work diligently to adapt its practices and maintain its product certifications, thereby safeguarding patient safety and ensuring product reliability.
How does Zynex, Inc. contribute to research and development?
Zynex, Inc. commits a significant portion of its resources to research and development (R&D) to advance its technology and product offerings. The company collaborates with various healthcare professionals and researchers to improve existing devices and develop new solutions that address unmet patient needs in pain management and rehabilitation.
How does Zynex, Inc. differentiate itself from competitors?
Zynex, Inc. differentiates itself from competitors through its commitment to innovation, quality, and customer service. The company continuously invests in research and development to enhance its product offerings, ensuring they meet the evolving needs of healthcare providers and patients, thereby establishing a strong competitive edge in the market.
Is Zynex, Inc. publicly traded?
Yes, Zynex, Inc. is publicly traded on the Nasdaq stock exchange under the ticker symbol ZYXI. The company became publicly listed to increase its capital for growth and development and to provide investors with the opportunity to participate in its future success.
What are some key milestones in Zynex, Inc.'s history?
Key milestones in Zynex, Inc.'s history include its founding in 1996, achieving FDA clearances for its flagship products, and becoming a publicly traded company on the Nasdaq exchange. Over the years, Zynex has also expanded its product line and market presence, reflecting its growth and commitment to innovation in the medical device industry.
What are Zynex, Inc.'s recent financial performance trends?
Zynex, Inc. has reported strong financial performance in recent years, with increasing revenues attributed to heightened demand for its medical devices. The company has also focused on improving profitability through operational efficiencies and expanding its market reach, contributing to a positive outlook for future financial health.
What does Zynex, Inc. do?
Zynex, Inc. is a medical technology company that specializes in the development and commercialization of non-invasive medical devices primarily focused on pain management, rehabilitation, and patient monitoring. Its flagship product line includes electrotherapy devices designed for the safe and effective treatment of pain and muscle stimulation, making it a vital player in the field of pain management therapy.
What initiatives does Zynex, Inc. have for corporate social responsibility?
Zynex, Inc. is dedicated to corporate social responsibility (CSR) by actively engaging in community outreach and educational initiatives. The company supports health awareness campaigns, contributes to local charities, and invests in local communities, reflecting its commitment to making a positive impact beyond its business operations.
What is the vision and mission of Zynex, Inc.?
Zynex, Inc.'s vision is to enhance the quality of life for patients by providing innovative and effective solutions for pain management and rehabilitation. The company's mission focuses on improving patient outcomes through non-invasive medical technology while fostering a culture of excellence, integrity, and service.
What is Zynex, Inc.'s approach to customer service?
Zynex, Inc. prioritizes customer service by offering comprehensive support to healthcare providers and patients. The company provides training, guidance, and technical support to ensure users can effectively utilize its products. This commitment to customer satisfaction helps build lasting relationships and aids in better patient care.
What is Zynex, Inc.'s business model?
Zynex, Inc. primarily operates through a direct sales model, marketing its products directly to healthcare providers and patients. The company also partners with distributors, enabling broader reach. This model allows Zynex to maintain close relationships with users of its products, ensuring tailored customer support and service.
What is Zynex, Inc.'s outlook for future growth?
Zynex, Inc. maintains a positive outlook for future growth, driven by the increasing demand for non-invasive pain management solutions and ongoing advancements in its product offerings. The company aims to expand its market share, enhance its research capabilities, and explore new opportunities in emerging markets, positioning itself for continued success in the healthcare industry.
What markets does Zynex, Inc. serve?
Zynex, Inc. serves several markets within the healthcare sector, focusing predominantly on pain management and rehabilitation. The company targets various customer segments, including hospitals, outpatient facilities, physical therapists, and individual patients who require non-invasive pain management solutions.
What regulatory approvals has Zynex, Inc. secured for its products?
Zynex, Inc. has secured multiple regulatory approvals for its products from the Food and Drug Administration (FDA), which include clearances for its electrotherapy devices. This regulatory compliance ensures that their products meet stringent safety and efficacy standards before being marketed to healthcare providers and patients.
What types of products does Zynex, Inc. offer?
Zynex, Inc. offers a range of medical devices, primarily focused on electrotherapy and pain management. The product line includes the NexWave, a device that uses electrical stimulation to relieve pain, and the ZYNex Patient Monitoring system. Their innovations aim to help patients recover from injuries more effectively and improve the overall quality of pain management.
When was Zynex, Inc. founded?
Zynex, Inc. was founded in the year 1996 by Thomas Sandgaard. Since its inception, the company has aimed at improving the quality of life for patients by providing innovative medical devices and solutions, and it has continually expanded its product offerings to better serve the healthcare market.
Where is Zynex, Inc. headquartered?
Zynex, Inc. is headquartered in Aurora, Colorado. The location allows the company to be centrally positioned within the U.S. healthcare market, enabling easy access to key stakeholders, including healthcare providers, distributors, and patients throughout the country.
Who are the key executives at Zynex, Inc.?
Key executives at Zynex, Inc. include Thomas Sandgaard, who serves as the President and CEO, and members of the management team who bring extensive experience in medical technology, business management, and operations. Their leadership plays a crucial role in steering the company's strategic direction and fostering innovation.
What is the current price of Zynex, Inc. - Common Stock?
The current price of Zynex, Inc. - Common Stock is 2.280
When was Zynex, Inc. - Common Stock last traded?
The last trade of Zynex, Inc. - Common Stock was at 11:14 am EDT on April 3rd, 2025
What is the market capitalization of Zynex, Inc. - Common Stock?
The market capitalization of Zynex, Inc. - Common Stock is 72.61M
How many shares of Zynex, Inc. - Common Stock are outstanding?
Zynex, Inc. - Common Stock has 31.85M shares outstanding.